Literature DB >> 10984190

Depletion of brain glutathione potentiates the effect of 6-hydroxydopamine in a rat model of Parkinson's disease.

J C García1, D Remires, A Leiva, R González.   

Abstract

In order to examine the possible role of rat brain glutathione depletion by diethyl maleate (DEM) in the potentiation of 6-hydroxydopamine (6-OHDA) neurotoxicity, the relationships between both effects were evaluated using the circling behavior test (CBT), and determining striatal glutathione S-transferase (GST)-specific activity. There were significant differences between the two studied groups: 6-OHDA and DEM + 6-OHDA lesioned animals in striatal glutathione (GSH) concentration at the moment of the lesion with 6-OHDA and also at the end of the experiment (30 d after 6-OHDA lesion). The circling behavior test following the administration of amphetamine was qualitatively different between both groups of simple- and double-damaged animals. In accordance with our results, DEM injury makes the animals more susceptible to brain-oxidative damage by 6-OHDA, which can indicate that in the double-damaged animal group, DEM could induce potentiation of the toxicity through striatal glutathione depletion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10984190     DOI: 10.1385/JMN:14:3:147

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  21 in total

Review 1.  Oxidation reactions in Parkinson's disease.

Authors:  C W Olanow
Journal:  Neurology       Date:  1990-10       Impact factor: 9.910

2.  Supersensitivity to apomorphine following destruction of the ascending dopamine neurons: quantification using the rotational model.

Authors:  J F Marshall; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1977-02-21       Impact factor: 4.432

3.  Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes.

Authors:  S Baez; J Segura-Aguilar; M Widersten; A S Johansson; B Mannervik
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

4.  Effect of diethylmaleate and other glutathione depletors on protein synthesis.

Authors:  L G Costa; S D Murphy
Journal:  Biochem Pharmacol       Date:  1986-10-01       Impact factor: 5.858

5.  6-Hydroxydopamine: evidence for superoxide radical as an oxidative intermediate.

Authors:  R E Heikkila; G Cohen
Journal:  Science       Date:  1973-08-03       Impact factor: 47.728

6.  Parkinson's disease: a disorder due to nigral glutathione deficiency?

Authors:  T L Perry; D V Godin; S Hansen
Journal:  Neurosci Lett       Date:  1982-12-13       Impact factor: 3.046

7.  Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.

Authors:  J Sian; D T Dexter; A J Lees; S Daniel; Y Agid; F Javoy-Agid; P Jenner; C D Marsden
Journal:  Ann Neurol       Date:  1994-09       Impact factor: 10.422

Review 8.  The oxidant stress hypothesis in Parkinson's disease: evidence supporting it.

Authors:  S Fahn; G Cohen
Journal:  Ann Neurol       Date:  1992-12       Impact factor: 10.422

9.  Effects of exogenous factors on the cerebral glutathione in rodents.

Authors:  E Bien; K Vick; G Skorka
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

10.  Biosynthesis and maintenance of GSH in primary astrocyte cultures: role of L-cystine and ascorbate.

Authors:  E O'Connor; A Devesa; C García; I R Puertes; A Pellín; J R Viña
Journal:  Brain Res       Date:  1995-05-22       Impact factor: 3.252

View more
  5 in total

1.  Beneficial Effect of Melatonin on Motor and Memory Disturbances in 6-OHDA-Lesioned Rats.

Authors:  Lyubka Tancheva; Maria Lazarova; Luciano Saso; Reni Kalfin; Miroslava Stefanova; Diamara Uzunova; Atanas G Atanasov
Journal:  J Mol Neurosci       Date:  2021-01-05       Impact factor: 3.444

2.  Synergy between glutathione peroxidase-1 and astrocytic growth factors suppresses free radical generation and protects dopaminergic neurons against 6-hydroxydopamine.

Authors:  Mossa Gardaneh; Mostafa Gholami; Nader Maghsoudi
Journal:  Rejuvenation Res       Date:  2011-01-11       Impact factor: 4.663

3.  Assessment of Protective Role of Multifunctional Dopamine Agonist D-512 Against Oxidative Stress Produced by Depletion of Glutathione in PC12 Cells: Implication in Neuroprotective Therapy for Parkinson's Disease.

Authors:  Chandrashekhar Voshavar; Mrudang Shah; Liping Xu; Aloke K Dutta
Journal:  Neurotox Res       Date:  2015-07-23       Impact factor: 3.911

4.  Preventive Effect of Two New Neurotensin Analogues on Parkinson's Disease Rat Model.

Authors:  Maria Lazarova; Andrey Popatanasov; Radoslav Klissurov; Svetlana Stoeva; Tamara Pajpanova; Reni Kalfin; Lyubka Tancheva
Journal:  J Mol Neurosci       Date:  2018-10-30       Impact factor: 3.444

5.  Neuroprotective Mechanisms of Three Natural Antioxidants on a Rat Model of Parkinson's Disease: A Comparative Study.

Authors:  Lyubka P Tancheva; Maria I Lazarova; Albena V Alexandrova; Stela T Dragomanova; Ferdinando Nicoletti; Elina R Tzvetanova; Yordan K Hodzhev; Reni E Kalfin; Simona A Miteva; Emanuela Mazzon; Nikolay T Tzvetkov; Atanas G Atanasov
Journal:  Antioxidants (Basel)       Date:  2020-01-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.